Abstract:The cyclic GMP-AMP synthase (cGAS) is a critical regulator of the innate immune response acting as a sensor of double-strand DNAs from pathogens or damaged host DNA. Upon activation, cGAS signals through the STING/TBK1/IRF3 pathway to induce interferon expression. Double stranded DNA viruses target the cGAS pathway to facilitate infection. In HPV positive cells that stably maintain viral episomes, the levels of cGAS were found to be significantly increased over those seen in normal human keratinocytes. Furthermore the downstream effectors of the cGAS pathway, STING and IRF3, were fully active in response to signaling from the secondary messenger cGAMP or poly (dA:dT). In HPV positive cells cGAS was detected in both cytoplasmic puncta as well as in DNA damage induced micronuclei. E6 was responsible for increased levels of cGAS that was dependent on inhibition of p53. CRISPR-Cas9 mediated knockout of cGAS prevented activation of STING and IRF3 but had a minimal effect on viral replication. A primary function of cGAS in HPV positive cells was in response to treatment with etoposide or cisplatin which lead to increased levels of H2AX phosphorylation and activation of caspase 3/7 cleavage while having only a minimal effect on activation of homologous recombination repair factors ATM, ATR or CHK2. In HPV positive cells cGAS was found to regulate the levels of the phosphorylated non-homologous end-joining kinase, DNA-PK, which may contribute to H2AX phosphorylation along with other factors. Importantly cGAS was also responsible for increased levels of DNA breaks along with enhanced apoptosis in HPV positive cells but not in HFKs. This study identifies an important and novel role for cGAS in mediating the response of HPV positive cells to chemotherapeutic drugs.

Genomic Instability and DNA Damage Repair Pathways Induced by Human Papillomaviruses

Toll-Like Receptors in Human Papillomavirus Infection

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

Human Papillomaviruses Target the DNA Damage Repair and Innate Immune Response Pathways to Allow for Persistent Infection

DNA damage response is hijacked by human papillomaviruses to complete their life cycle

Engagement of Programmed Cell Death 1 and Its Ligands in Human Papillomaviurs Related Diseases

The Causes and Consequences of DNA Damage and Chromosomal Instability Induced by Human Papillomavirus

Human papillomavirus infection and host innate immune responses

Advances on Autophagy and Human Papillomavirus

Mechanism of Human Papillomavirus Infection on the Dendritic Cells

Autophagy is Induced in Human Keratinocytes During Human Papillomavirus 11 Pseudovirion Entry

How Human Papillomavirus Replication and Immune Evasion Strategies Take Advantage of the Host DNA Damage Repair Machinery

Pathogenesis of Human Papillomaviruses Requires the ATR/p62 Autophagy-Related Pathway

DNA damage response and inflammatory response: Two traffic lights for HPVs on the road to transformation

Human papillomavirus molecular biology and disease association

Human papillomaviruses sensitize cells to DNA damage induced apoptosis by targeting the innate immune sensor cGAS

Human Papillomavirus Targets the YAP1-LATS2 Feedback Loop to Drive Cervical Cancer Development.

HPV-driven oncogenesis—much more than the E6 and E7 oncoproteins

Induction of Co-Inhibitory Molecule CTLA-4 by Human Papillomavirus E7 Protein Through Downregulation of Histone Methyltransferase JHDM1B Expression

The APOBEC3 genes and their role in cancer: insights from human papillomavirus

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability